Английская Википедия:Anna-Lise Williamson

Материал из Онлайн справочника
Версия от 05:09, 1 февраля 2024; EducationBot (обсуждение | вклад) (Новая страница: «{{Английская Википедия/Панель перехода}} {{short description|Professor of Virology}} {{Use dmy dates|date=April 2022}} {{Infobox scientist | name = Anna-Lise Williamson | image = <!-- (filename only, i.e. without "File:" prefix) --> | image_size = | alt = | caption = | birth_date = <!-- {{birth date |YYYY|MM|DD}} --> | birth_place = | death_date = <!-- {{death date and age |...»)
(разн.) ← Предыдущая версия | Текущая версия (разн.) | Следующая версия → (разн.)
Перейти к навигацииПерейти к поиску

Шаблон:Short description Шаблон:Use dmy dates Шаблон:Infobox scientist

Anna-Lise Williamson Шаблон:Post-nominals MASSAf is a Professor of Virology at the University of Cape Town.Шаблон:R Williamson obtained her PhD from the University of the Witwatersrand in 1985. Her area of expertise is human papillomavirus, but is also known on an international level for her work in developing vaccines for HIV. These vaccines have been introduce in phase 1 of clinical trial. Williamson has published more than 120 papers.Шаблон:R

Education

Williamson received a PhD at the University of the Witwatersrand in 1985. Her Ph.D. thesis was entitled "An Electron Microscopic and Immunocytochemical Study of Jaagsiekte".Шаблон:Sfn Williamson was also a fellow at the Royal Society of South AfricaШаблон:R and at the University of Cape Town.Шаблон:R

Accomplishments

Anna-Lise Williamson is the Director of University of the Cape Town vaccine Research group GLP. Her area of expertise and what she is best known for is Human Papillomavirus and HIV Vaccines.Шаблон:R

  • Awarded a Chair in Vaccinology 2008 (South African Research Chairs Initiative)
  • Head of World Health Organization human papillomavirus Labnet lab for the Africa Region
  • Joint Head of University of Cape Town, National Institute for communicable Diseases, and National health Laboratory Service Molecular Epidemiology Laboratory
  • Member of the South African HPV Advisory BoardШаблон:R
  • Member of the Academy of Science of South Africa Шаблон:R

Contributions

Anna-Lise Williamson is the head of the HIV vaccine development and human papilloma research group at the University of Cape Town. There, Williamson and a team of over 30 people are developing vaccines for HIV-1 subtype C virus. This strain is known to be the most Virulent,Шаблон:R and known to be the principle strain that leads to AIDS.The goal of the investigation is to create affordable and effective HIV-1 C vaccines,Шаблон:R that would increase the longevity of memory T cells and develop a more functional use of the CD4+ and CD8+ cell response.Шаблон:R Two vaccines have been selected to move forward in clinical trials. These vaccines are DNA vaccines and a modified vaccinia virus Ankara vaccine. The vaccines were developed as part of the South African AIDS Vaccine Initiative (SAAVI).Шаблон:R

Selected publications

Anna-Lise Williamson has published over 120 papers. Her publications mainly consists of her area of expertise addressing HIV vaccine development, HIV virus, and HPV virus.

References

Шаблон:Reflist

Sources

Шаблон:Refbegin

Шаблон:Refend

External links

Шаблон:Authority control